Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Amanda D. Morgan, Daryl Ramai, Praneeth Bandaru, Stefano Francesco Crino and Antonio Facciorusso*

DOI: 10.2174/1871530323666230411141412

DownloadDownload PDF Flyer Cite As
Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors

Page: [1355 - 1358] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Pancreatic neuroendocrine neoplasms (PNETs) are rare but can be associated with significant morbidity and mortality. PNETs can be difficult to diagnose and have a propensity for metastasis before their diagnosis is established. To this end, many PNETs do not become apparent until late in their clinical course. Endoscopic ultrasound (EUS) has become the modality of choice for detecting these lesions due to its high tumor detection rate. Additionally, therapeutic techniques have arisen from EUS which allow for the treatment of PNETs. Overall, EUS has become a powerful diagnostic and therapeutic modality for addressing pancreatic lesions such as PNETs. In this perspective article, we provide an overview of the therapeutic potentials of EUS in the management of PNETs.

[1]
Ito, T.; Sasano, H.; Tanaka, M.; Osamura, R.Y.; Sasaki, I.; Kimura, W.; Takano, K.; Obara, T.; Ishibashi, M.; Nakao, K.; Doi, R.; Shimatsu, A.; Nishida, T.; Komoto, I.; Hirata, Y.; Nakamura, K.; Igarashi, H.; Jensen, R.T.; Wiedenmann, B.; Imamura, M. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J. Gastroenterol., 2010, 45(2), 234-243.
[http://dx.doi.org/10.1007/s00535-009-0194-8] [PMID: 20058030]
[2]
Yao, J.C.; Hassan, M.; Phan, A.; Dagohoy, C.; Leary, C.; Mares, J.E.; Abdalla, E.K.; Fleming, J.B.; Vauthey, J.N.; Rashid, A.; Evans, D.B. One hundred years after “carcinoid”: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol., 2008, 26(18), 3063-3072.
[http://dx.doi.org/10.1200/JCO.2007.15.4377] [PMID: 18565894]
[3]
Metz, D.C.; Jensen, R.T. Gastrointestinal neuroendocrine tumors: Pancreatic endocrine tumors. Gastroenterology, 2008, 135(5), 1469-1492.
[http://dx.doi.org/10.1053/j.gastro.2008.05.047] [PMID: 18703061]
[4]
Öberg, K. Pancreatic endocrine tumors. Semin. Oncol., 2010, 37(6), 594-618.
[http://dx.doi.org/10.1053/j.seminoncol.2010.10.014] [PMID: 21167379]
[5]
Citterio, D.; Pusceddu, S.; Facciorusso, A.; Coppa, J.; Milione, M.; Buzzoni, R.; Bongini, M.; deBraud, F.; Mazzaferro, V. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver. Eur. J. Surg. Oncol., 2017, 43(2), 380-387.
[http://dx.doi.org/10.1016/j.ejso.2016.10.031] [PMID: 27956320]
[6]
Tacelli, M.; Bina, N.; Crinò, S.F.; Facciorusso, A.; Celsa, C.; Sbrozzi Vanni, A.; Fantin, A.; Antonini, F.; Falconi, M.; Monica, F.; Capurso, G.; Arcidiacono, P.G.; Barresi, L. Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: A systematic review with meta-analysis of aggregate and individual data. Gastrointest. Endosc., 2022, 96(6), 898-908.
[7]
Facciorusso, A.; Kovacevic, B.; Yang, D.; Vilas-Boas, F.; Martínez-Moreno, B.; Stigliano, S.; Rizzatti, G.; Sacco, M.; Arevalo-Mora, M.; Villarreal-Sanchez, L.; Conti Bellocchi, M.C.; Bernardoni, L.; Gabbrielli, A.; Barresi, L.; Gkolfakis, P.; Robles-Medranda, C.; De Angelis, C.; Larghi, A.; Di Matteo, F.M.; Aparicio, J.R.; Macedo, G.; Draganov, P.V.; Vilmann, P.; Pecchia, L.; Repici, A.; Crinò, S.F. Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: A recursive partitioning analysis. Endoscopy, 2022, 54(12), 1158-1168.
[http://dx.doi.org/10.1055/a-1831-5385]
[8]
Gkolfakis, P.; Crinò, S.F.; Tziatzios, G.; Ramai, D.; Papaefthymiou, A.; Papanikolaou, I.S.; Triantafyllou, K.; Arvanitakis, M.; Lisotti, A.; Fusaroli, P.; Mangiavillano, B.; Carrara, S.; Repici, A.; Hassan, C.; Facciorusso, A. Comparative diagnostic performance of end-cutting fine-needle biopsy needles for EUS tissue sampling of solid pancreatic masses: A network meta-analysis. Gastrointest. Endosc., 2022, 95(6), 1067-1077.
[http://dx.doi.org/10.1016/j.gie.2022.01.019] [PMID: 35124072]
[9]
Crinò, S.F.; Ammendola, S.; Meneghetti, A.; Bernardoni, L.; Conti Bellocchi, M.C.; Gabbrielli, A.; Landoni, L.; Paiella, S.; Pin, F.; Parisi, A.; Mastrosimini, M.G.; Amodio, A.; Frulloni, L.; Facciorusso, A.; Larghi, A.; Manfrin, E. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors. Pancreatology, 2021, 21(2), 443-450.
[http://dx.doi.org/10.1016/j.pan.2020.12.015] [PMID: 33390343]
[10]
Jürgensen, C.; Schuppan, D.; Neser, F.; Ernstberger, J.; Junghans, U.; Stölzel, U. EUS-guided alcohol ablation of an insulinoma. Gastrointest. Endosc., 2006, 63(7), 1059-1062.
[http://dx.doi.org/10.1016/j.gie.2005.10.034] [PMID: 16733126]
[11]
Muscatiello, N.; Salcuni, A.; Macarini, L.; Cignarelli, M.; Prencipe, S.; Maso, M.; Castriota, M.; D’Agnessa, V.; Ierardi, E. Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. Endoscopy, 2008, 40(S02), E258-E259.
[http://dx.doi.org/10.1055/s-2007-966962] [PMID: 19090457]
[12]
Choi, J.H.; Park, D.H.; Kim, M.H.; Hwang, H.S.; Hong, S.M.; Song, T.J.; Lee, S.S.; Seo, D.W.; Lee, S.K. Outcomes after endoscopic ultrasound‐guided ethanol‐lipiodol ablation of small pancreatic neuroendocrine tumors. Dig. Endosc., 2018, 30(5), 652-658.
[http://dx.doi.org/10.1111/den.13058] [PMID: 29575213]
[13]
So, H.; Ko, S.W.; Shin, S.H.; Kim, E.H.; Son, J.; Ha, S.; Song, K.B.; Kim, H.J.; Kim, M.H.; Park, D.H. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: A propensity score-matching study. Gastrointest Endosc, 2022, 97(4), 741-751.
[http://dx.doi.org/10.1016/j.gie.2022.11.004]
[14]
Facciorusso, A.; Di Maso, M.; Serviddio, G.; Larghi, A.; Costamagna, G.; Muscatiello, N. Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcinoma. J. Gastroenterol. Hepatol., 2017, 32(2), 439-445.
[http://dx.doi.org/10.1111/jgh.13478] [PMID: 27356212]
[15]
Facciorusso, A.; Abd El Aziz, M.A.; Tartaglia, N.; Ramai, D.; Mohan, B.P.; Cotsoglou, C.; Pusceddu, S.; Giacomelli, L.; Ambrosi, A.; Sacco, R. Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: A meta-analysis of randomized controlled trials. Cancers, 2020, 12(12), 3796.
[http://dx.doi.org/10.3390/cancers12123796] [PMID: 33339274]
[16]
Facciorusso, A.; Prete, V.D.; Crucinio, N.; Serviddio, G.; Vendemiale, G.; Muscatiello, N. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. World J. Gastroenterol., 2016, 22(16), 4211-4218.
[http://dx.doi.org/10.3748/wjg.v22.i16.4211] [PMID: 27122671]
[17]
Armellini, E.; Crinò, S.; Ballarè, M.; Occhipinti, P. Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor. Endoscopy, 2015, 47(S01), E600-E601.
[http://dx.doi.org/10.1055/s-0034-1393677] [PMID: 26671543]
[18]
Paiella, S.; De Pastena, M.; D’Onofrio, M.; Crinò, S.F.; Pan, T.L.; De Robertis, R.; Elio, G.; Martone, E.; Bassi, C.; Salvia, R. Palliative therapy in pancreatic cancer—interventional treatment with radiofrequency ablation/irreversible electroporation. Transl. Gastroenterol. Hepatol., 2018, 3, 80.
[http://dx.doi.org/10.21037/tgh.2018.10.05] [PMID: 30505967]
[19]
Limmer, S.; Huppert, P.E.; Juette, V.; Lenhart, A.; Welte, M.; Wietholtz, H. Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia. Eur. J. Gastroenterol. Hepatol., 2009, 21(9), 1097-1101.
[http://dx.doi.org/10.1097/MEG.0b013e328323d70e] [PMID: 19685572]
[20]
Choi, J.H.; Seo, D.W.; Song, T.J.; Park, D.H.; Lee, S.S.; Lee, S.K.; Kim, M.H. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors. Endoscopy, 2018, 50(11), 1099-1104.
[http://dx.doi.org/10.1055/a-0583-8387] [PMID: 29727904]
[21]
Barthet, M.; Giovannini, M.; Lesavre, N.; Boustiere, C.; Napoleon, B.; Koch, S.; Gasmi, M.; Vanbiervliet, G.; Gonzalez, J.M. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: A prospective multicenter study. Endoscopy, 2019, 51(9), 836-842.
[http://dx.doi.org/10.1055/a-0824-7067] [PMID: 30669161]
[22]
Oleinikov, K.; Dancour, A.; Epshtein, J.; Benson, A.; Mazeh, H.; Tal, I.; Matalon, S.; Benbassat, C.A.; Livovsky, D.M.; Goldin, E.; Gross, D.J.; Jacob, H.; Grozinsky-Glasberg, S. Endoscopic ultrasound-guided radiofrequency ablation: A new therapeutic approach for pancreatic neuroendocrine tumors. J. Clin. Endocrinol. Metab., 2019, 104(7), 2637-2647.
[http://dx.doi.org/10.1210/jc.2019-00282] [PMID: 31102458]
[23]
Garg, R.; Mohammed, A.; Singh, A.; Harnegie, M.; Rustagi, T.; Stevens, T.; Chahal, P. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: A systematic review and meta-analysis. Endosc. Ultrasound, 2022, 11(3), 170-185.
[http://dx.doi.org/10.4103/EUS-D-21-00044] [PMID: 35313416]
[24]
El Sayed, G.; Frim, L.; Franklin, J.; McCrudden, R.; Gordon, C.; Al-Shamma, S.; Kiss, S.; Hegyi, P.; Erőss, B.; Hegyi, P.J. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: A systematic literature review. Therap. Adv. Gastroenterol., 2021, 14.
[http://dx.doi.org/10.1177/17562848211042171] [PMID: 34819995]
[25]
Melita, G.; Pallio, S.; Tortora, A.; Crinò, S.F.; Macrì, A.; Dionigi, G. Diagnostic and interventional role of endoscopic ultrasonography for the management of pancreatic neuroendocrine neoplasms. J. Clin. Med., 2021, 10(12), 2638.
[http://dx.doi.org/10.3390/jcm10122638] [PMID: 34203922]
[26]
Crinò, S.F.; Napoleon, B.; Facciorusso, A.; Lakhtakia, S.; Borbath, I.; Caillol, F.; Do-Cong Pham, K.; Rizzatti, G.; Forti, E.; Palazzo, L.; Belle, A.; Vilmann, P.; van Laethem, J.L.; Mohamadnejad, M.; Godat, S.; Hindryckx, P.; Benson, A.; Tacelli, M.; De Nucci, G.; Binda, C.; Kovacevic, B.; Jacob, H.; Partelli, S.; Falconi, M.; Salvia, R.; Landoni, L. Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma. Clin. Gastroenterol. Hepatol., 2023, 2023, S1542-3565(23)00165-9.
[27]
Facciorusso, A.; Di Maso, M.; Serviddio, G.; Vendemiale, G.; Spada, C.; Costamagna, G.; Muscatiello, N. Factors associated with recurrence of advanced colorectal adenoma after endoscopic resection. Clin. Gastroenterol. Hepatol., 2016, 14(8), 1148-1154.e4.
[http://dx.doi.org/10.1016/j.cgh.2016.03.017] [PMID: 27005802]